| Autor: |
Harmon KG; Department of Family Medicine and Center for Sports Cardiology, University of Washington, Seattle (J.A.D., D.M.S., L.S., M.Z.S., K.G.H.)., Churchill TW; Division of Cardiology (B.J.P., T.W.C., A.L.B.), Massachusetts General Hospital, Boston.; Cardiovascular Performance Program (B.J.P., T.W.C., A.L.B.), Massachusetts General Hospital, Boston., Moulson N; Division of Cardiology and Sports Cardiology BC, University of British Columbia, Vancouver, Canada (N.M.)., Kliethermes SA; Department of Orthopedics and Rehabilitation, University of Wisconsin Madison (S.A.K.)., Baggish AL; Division of Cardiology (B.J.P., T.W.C., A.L.B.), Massachusetts General Hospital, Boston.; Cardiovascular Performance Program (B.J.P., T.W.C., A.L.B.), Massachusetts General Hospital, Boston.; Swiss Olympic Medical Center, Lausanne University Hospital (CHUV), Switzerland (A.L.B.).; Institute for Sport Science, University of Lausanne (ISSUL), Switzerland (A.L.B.)., Drezner JA; Department of Family Medicine and Center for Sports Cardiology, University of Washington, Seattle (J.A.D., D.M.S., L.S., M.Z.S., K.G.H.)., Patel MR; Division of Cardiology, Duke Heart Center, and Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (M.R.P.)., Ackerman MJ; Department of Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory (M.J.A.), Mayo Clinic, Rochester, MN.; Department of Cardiovascular Medicine, Division of Heart Rhythm Services, Windland Smith Rice Genetic Heart Rhythm Clinic (M.J.A.), Mayo Clinic, Rochester, MN.; Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology (M.J.A.), Mayo Clinic, Rochester, MN., Siebert DM; Department of Family Medicine and Center for Sports Cardiology, University of Washington, Seattle (J.A.D., D.M.S., L.S., M.Z.S., K.G.H.)., Salerno L; Department of Family Medicine and Center for Sports Cardiology, University of Washington, Seattle (J.A.D., D.M.S., L.S., M.Z.S., K.G.H.)., Zigman Suchsland M; Department of Family Medicine and Center for Sports Cardiology, University of Washington, Seattle (J.A.D., D.M.S., L.S., M.Z.S., K.G.H.)., Asif IM; Family and Community Medicine, The University of Alabama at Birmingham Heersink School of Medicine (I.M.A.)., Maleszewski JJ; Department of Laboratory Medicine & Pathology (J.J.M.), Mayo Clinic, Rochester, MN., Petek BJ; Sports Cardiology Program, Knight Cardiovascular Institute, Oregon Health and Science University, Portland (B.J.P.).; Division of Cardiology (B.J.P., T.W.C., A.L.B.), Massachusetts General Hospital, Boston.; Cardiovascular Performance Program (B.J.P., T.W.C., A.L.B.), Massachusetts General Hospital, Boston. |
| Abstrakt: |
Competing Interests: Dr Ackerman is a consultant for Abbott, Boston Scientific, Bristol Myers Squibb, Daiichi Sankyo, Invitae, Medtronic, Tenaya Therapeutics, Thryv Therapeutics, and UpToDate. Dr Ackerman and Mayo Clinic are involved in an equity/royalty relationship with AliveCor, Anumana, ARMGO Pharma, and Pfizer. None of these entities was involved in this study. Dr Baggish has received funding from the National Institute of Health/National Heart, Lung, and Blood Institute, the National Football Players Association, the American Heart Association, and the American Medical Society for Sports Medicine to study cardiovascular outcomes among elite athletes and receives compensation for his role as team cardiologist from the US Olympic Committee/US Olympic Training Centers, US Soccer, and US Rowing. Dr Drezner has received funding from the American Medical Society for Sports Medicine, the American Heart Association, and the National Center for Catastrophic Sports Injury Research. Dr Harmon has received funding from the American Medical Society for Sports Medicine, Football Research, Inc, the Pac- 12, and the American Heart Association. |
